Search for: "Celgene Corp."
Results 21 - 40
of 81
Sorted by Relevance
|
Sort by Date
3 Jun 2010, 9:36 pm
By James DeGiulio -- Celgene, Barr Resolve Patent Dispute over Generic Thalomid Celgene Corp. and Barr Laboratories Inc. have resolved their patent dispute over the multiple myeloma cancer drug Thalomid, with Celgene agreeing to drop its patent infringement claims and Barr dropping its invalidity and antitrust claims. [read post]
21 Jun 2010, 7:29 am
Browsing through Friday afternoon’s filings over the Father’s Day weekend, we found an 8-K filed by biopharmaceutical maker Celgene Corp. [read post]
11 Aug 2019, 9:15 am
The case of Celgene Corp. v. [read post]
14 Apr 2020, 1:20 pm
Just as it did in other cases raising Patent Trial and Appeal Board (PTAB)-related Takings Clause issues, the appellate court in Golden relied on its July 2019 decision in Celgene Corp. v. [read post]
5 Nov 2021, 8:29 am
Corp., 247 F.3d 471, 484 & n.2 (3d Cir. 2001). [read post]
1 Oct 2008, 3:58 pm
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, And Erythema Multiforme Are Associated With Revlimid Use (Posted by Tom Lamb at DrugInjuryWatch.com) The Summer 2008 edition of the US FDA's Drug Safety Newsletter included an article concerning Revlimid (lenalidomide), a thalidomide analogue marketed by Celgene Corp. [read post]
17 Jun 2015, 10:44 am
Celgene Corp., 985 F. [read post]
15 Jul 2018, 8:44 pm
Celgene Corp. v. [read post]
27 Sep 2015, 10:00 pm
Celgene Corp. had filed motions for sanctions in IPRs brought against its patents relating to Thalomid® (thalidomide) and Revlamid®... [read post]
27 Sep 2015, 10:00 pm
Celgene Corp. had filed motions for sanctions in IPRs brought against its patents relating to Thalomid® (thalidomide) and Revlamid®... [read post]
27 Jul 2017, 2:42 pm
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit… The post Pharmaceutical Manufacturer Agrees to Pay $280 Million to Settle Healthcare Whistleblower Lawsuit appeared first on TZ Legal - Fraud Fighters. [read post]
3 Aug 2015, 10:00 pm
Celgene Corp. [read post]
27 Jul 2017, 10:37 am
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit related to allegations that it promoted cancer drugs for uses that had not been approved by the Food and Drug Administration (“FDA”). [read post]
27 Jul 2017, 10:37 am
Celgene Corp., a New Jersey pharmaceutical manufacturer, has agreed to pay $280 million to settle a False Claims Act lawsuit related to allegations that it promoted cancer drugs for uses that had not been approved by the Food and Drug Administration (“FDA”). [read post]
7 Aug 2019, 2:15 pm
But early last week, the Federal Circuit for the first time addressed the applicability of the Takings Clause of the Fifth Amendment to IPRs, holding in Celgene Corp. v. [read post]
17 Apr 2014, 8:07 am
In Andrulis Pharmaceuticals Corp. v. [read post]
6 Aug 2019, 10:00 pm
” In Celgene Corp. v. [read post]
7 Nov 2019, 8:10 pm
Notable advances include Takeda (up 142% based in part on its Shire acquisition, and jumping in the rankings from 23rd to 17th Q4 2018 – Q1 2019), with several other companies showing robust growth (including Celgene Corp., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
17 Jan 2007, 1:23 pm
On Wednesday, December 13, 2006, Celgene Corp. announced that it had received notification from Barr Laboratories, Inc. that Barr had filed an ANDA for generic thalidomide, 200 mg tablets, sold by Celgene under the brand name Thalomid. [read post]
4 May 2014, 9:39 pm
Celgene Corp. et... [read post]
